Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02381886
Title A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | ESP | DEU | CAN | BEL | AUS

Facility Status City State Zip Country Details
Dana Farber Cancer Institute SC (1) Boston Massachusetts 02115 United States Details
Columbia University Medical Center- New York Presbyterian Onc Dept. New York New York 10032 United States Details
Uni of TX MD Anderson Cancer Cntr . Houston Texas 77030 United States Details
Novartis Investigative Site Melbourne Victoria 3004 Australia Details
Novartis Investigative Site Parkville Victoria 3050 Australia Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site Heidelberg 69120 Germany Details
Novartis Investigative Site Jena 07740 Germany Details
Novartis Investigative Site Koeln 50937 Germany Details
ErasmusMC Cancer lnstitute, Neuro-Oncology, Rm G3-55 Rotterdam 3075 EA Netherlands Details
Novartis Investigative Site Singapore 168583 Singapore Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field